Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$751M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$692M |
| 3 |
Palantir
PLTR
|
+$434M |
| 4 |
Union Pacific
UNP
|
+$377M |
| 5 |
AbbVie
ABBV
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.74B |
| 2 |
Meta Platforms (Facebook)
META
|
+$602M |
| 3 |
Bank of America
BAC
|
+$600M |
| 4 |
Wells Fargo
WFC
|
+$568M |
| 5 |
Broadcom
AVGO
|
+$538M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.73% |
| 2 | Financials | 7.42% |
| 3 | Healthcare | 6.65% |
| 4 | Industrials | 6.3% |
| 5 | Consumer Discretionary | 5.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
CALL
Delta Air Lines
DAL
$55B
| $17.1M | 0.01% |
347,900
-20,900
| -6% | -$960K |
|
|
ETOR
1677
eToro Group
ETOR
$2.46B
| $17.1M | 0.01% |
+256,910
| New | +$16.5M |
|
1678
BioCryst Pharmaceuticals
BCRX
$2.51B
| $17.1M | 0.01% |
1,906,667
-1,906,207
| -50% | -$17.8M |
|
1679
CALL
Zoom
ZM
$29.6B
| $17.1M | 0.01% |
219,000
-60,200
| -22% | -$4.65M |
|
1680
Leggett & Platt
LEG
$1.27B
| $17M | 0.01% |
1,907,642
-2,697,774
| -59% | -$23.2M |
|
1681
Microvast
MVST
$302M
| $17M | 0.01% |
4,687,392
+41,332
| +0.9% | +$121K |
|
1682
United Parks & Resorts
PRKS
$1.98B
| $17M | 0.01% |
360,172
+351,423
| +4,017% | +$15.7M |
|
1683
ESCO Technologies
ESE
$7.17B
| $17M | 0.01% |
88,413
+67,349
| +320% | +$11.5M |
|
1684
Realty Income
O
$59.5B
| $17M | 0.01% |
294,346
+249,913
| +562% | +$14.1M |
|
|
XHR
1685
Xenia Hotels & Resorts
XHR
$1.82B
| $17M | 0.01% |
1,348,484
-777,714
| -37% | -$8.9M |
|
1686
VICI Properties
VICI
$28.9B
| $16.9M | 0.01% |
519,596
+154,348
| +42% | +$4.91M |
|
1687
CALL
Lyft
LYFT
$6.68B
| $16.9M | 0.01% |
1,074,500
+623,100
| +138% | +$8.73M |
|
1688
FirstCash
FCFS
$9.95B
| $16.9M | 0.01% |
124,974
-168,776
| -57% | -$21.6M |
|
1689
PUT
Zimmer Biomet
ZBH
$19.1B
| $16.9M | 0.01% |
185,000
+164,600
| +807% | +$15.9M |
|
1690
Kenvue
KVUE
$37.1B
| $16.9M | 0.01% |
806,006
-1,275,670
| -61% | -$29M |
|
1691
CALL
Nutanix
NTNX
$18B
| $16.8M | 0.01% |
220,200
+117,900
| +115% | +$8.49M |
|
1692
Nutrien
NTR
$34.8B
| $16.8M | 0.01% |
288,682
+242,064
| +519% | +$13.7M |
|
|
AKRO
1693
DELISTED
Akero Therapeutics
AKRO
| $16.8M | 0.01% |
314,989
+84,125
| +36% | +$3.82M |
|
1694
Royalty Pharma
RPRX
$27.6B
| $16.8M | 0.01% |
466,431
+157,261
| +51% | +$5.21M |
|
|
BOW
1695
Bowhead Specialty Holdings
BOW
$1.11B
| $16.8M | 0.01% |
447,479
+197,202
| +79% | +$7.55M |
|
1696
OrthoPediatrics
KIDS
$640M
| $16.8M | 0.01% |
781,027
+124,449
| +19% | +$2.69M |
|
1697
UL Solutions
ULS
$14.9B
| $16.8M | 0.01% |
230,239
+42,049
| +22% | +$2.75M |
|
1698
Nektar Therapeutics
NKTR
$2.56B
| $16.8M | 0.01% |
649,033
+496,446
| +325% | +$5.57M |
|
1699
MannKind Corp
MNKD
$1.34B
| $16.8M | 0.01% |
4,481,526
-1,341,064
| -23% | -$5.91M |
|
1700
iShares Russell 2000 ETF
IWM
$81.7B
| $16.7M | 0.01% |
77,514
-727,104
| -90% | -$146M |
|
Similar funds
Israel Englander's Q2 2025 Portfolio in Review
As of Q2 2025, Israel Englander held 6,516 positions worth $207B, up 10% from $188B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Israel Englander's Q2 2025 filing shows 738 new, 2,295 increased, 2,418 reduced and 712 closed positions. Its largest new stake was Bank of America Series L: 164,000 shares worth $197K. The largest sale was iShares Core S&P 500 ETF, an estimated $1.74B.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 7.8% a quarter earlier, followed by Financials and Healthcare.
- Israel Englander's largest Q2 2025 buy was Bank of America Series L: 164,000 shares worth $197K.
- Israel Englander added most to Applovin in Q2 2025, an estimated $751M increase.
- Israel Englander's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.74B.
- Israel Englander fully exited Discover Financial Services in Q2 2025, selling an estimated $282M.
- Israel Englander's ten largest holdings make up 16% of its $207B portfolio in Q2 2025.
- Israel Englander opened 738 new positions and closed 712 in Q2 2025.
- Israel Englander's portfolio value rose 10% quarter-over-quarter to $207B.
Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.